Candel Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:CADL) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 89.2 M77.69 M41.2 M106.87 M125.19 M 총 부채 25.07 M29.98 M28.46 M40.54 M73.27 M 자본금 총액 64.14 M47.71 M12.74 M66.33 M51.92 M 총 부채 및 주주자본 89.2 M77.69 M41.2 M106.87 M125.19 M 총부채 —20.85 M11.63 M1.73 M47.13 M 순부채 —-49.21 M11.63 M1.73 M-72.6 M

뉴스

Wall Street Analysts Believe Candel Therapeutics (CADL) Could Rally 148.48%: Here's is How to Trade

Candel Therapeutics, Inc. (CADL) Discusses Extended Follow-Up Data From Phase 3 Trial of aglatimagene besadenovec in Localized Prostate Cancer Transcript

Candel reports extended survival data for lung cancer therapy

H.C. Wainwright, 캔델 테라퓨틱스에 ’매수’ 의견 유지

H.C. Wainwright reiterates Candel Therapeutics stock rating at buy

캔델, 전립선암 임상 시험 데이터 구두 발표 예정

Candel announces oral presentation on prostate cancer trial data

폴 매닝, 캔델 테라퓨틱스(CADL) 주식 3백만 달러 상당 매입

캔델 테라퓨틱스, 1억 달러 규모 공모에 주가 하락

Candel Therapeutics stock falls on $100 million offering pricing

Why Is Candel Therapeutics Stock Falling Friday? - Candel Therapeutics (NASDAQ:CADL)

New Strong Sell Stocks for January 20th